Emily Jane Cook

Emily Jane Cook

McDermott Will & Emery

Contact

Readers' Choice Awards

Healthcare
Life Sciences
View Bio
RSS

Latest Posts › Covered Entities

Share:

This Week in 340B: October 2023

This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick...more

10/13/2023  /  Covered Entities , Department of Health and Human Services (HHS) , Health Care Providers , Healthcare , Healthcare Reform , Litigation Strategies , Medicare , Prescription Drugs , Section 340B

This Week in 340B: September 2023 #5

This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick...more

10/4/2023  /  Covered Entities , Health Care Providers , Healthcare , Healthcare Reform , Pharmaceutical Industry , Pharmacies , Prescription Drugs , Section 340B

This Week in 340B: September 2023 #3

This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick...more

9/20/2023  /  Covered Entities , Drug Pricing , Health Care Providers , Healthcare , Hospitals , Medicare , Patients , Pharmaceutical Industry , Prescription Drugs , Section 340B

This Week in 340B: August 2023 #2

This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick...more

8/22/2023  /  Covered Entities , Department of Health and Human Services (HHS) , Drug Pricing , Medicaid , Medicare , Medicare Part B , Pharmaceutical Industry , Pharmacies , Prescription Drugs , Section 340B

This Week in 340B: July 2023 #2

This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets on more than 40 340B cases to provide you with a quick...more

7/19/2023  /  Covered Entities , Healthcare , Medicaid , Medicare , Pharmaceutical Industry , Pharmacies , Prescription Drugs , Section 340B

This Week in 340B: July 2023

This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets on more than 40 340B cases to provide you with a quick...more

7/6/2023  /  Covered Entities , Healthcare , Medicaid , Pharmaceutical Industry , Pharmacies , Preliminary Injunctions , Prescription Drugs , Section 340B

This Week in 340B: June 2023 #4

This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets on more than 40 340B cases to provide you with a quick...more

6/28/2023  /  Class Action , Covered Entities , Criminal Antitrust Litigation , Healthcare , Medicaid , Medicare , Motion to Dismiss , Pharmaceutical Industry , Prescription Drugs , Section 340B

This Week in 340B: June 2023 #3

This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets on more than 40 340B cases to provide you with a quick...more

6/22/2023  /  Covered Entities , Drug Pricing , Pharmacies , Prescription Drugs , Section 340B , Summary Judgment

California Considers Bill to Protect 340B Covered Entities from PBM Discrimination

The California State Senate recently passed legislation that would prohibit pharmacy benefit managers (PBMs) from discriminating against entities participating in the 340B Drug Pricing Program (340B covered entities). SB 786...more

6/22/2023  /  California , Covered Entities , Pharmacy Benefit Manager (PBM) , Section 340B

This Week in 340B: May 2023 #4

This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets on more than 40 340B cases to provide you with a quick...more

6/1/2023  /  Arbitration , Centers for Medicare & Medicaid Services (CMS) , Covered Entities , Declaratory Judgments , Department of Health and Human Services (HHS) , Drug Pricing , Health Care Providers , Medicare , Pharmaceutical Industry , Pharmacies , Prescription Drugs , Section 340B

This Week in 340B: May 2023 #3

This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets on more than 40 340B cases to provide you with a quick...more

5/24/2023  /  American Hospital Association et al v Becerra Secretary Of Health And Human Services et al , Antitrust Division , Class Action , Covered Entities , Drug Pricing , Medicare , Motion to Dismiss , Oral Argument , Pharmaceutical Industry , Pharmacies , Prescription Drugs , Section 340B

This Week in 340B: May 2023 #2

This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets on more than 40 340B cases to provide you with a quick...more

5/17/2023  /  Covered Entities , Healthcare , Medicaid , Medicare , Pharmaceutical Industry , Pharmacies , Prescription Drugs , Section 340B

This Week in 340B: April 2023 #5

This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets on more than 40 340B cases to provide you with a quick...more

5/3/2023  /  American Hospital Association et al v Becerra Secretary Of Health And Human Services et al , Covered Entities , Department of Health and Human Services (HHS) , Drug Pricing , Health Care Providers , Medicare , Pharmaceutical Industry , Preliminary Injunctions , Prescription Drugs , Section 340B

This Week in 340B: April 2023 #4

This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets on more than 40 340B cases to provide you with a quick...more

4/27/2023  /  Covered Entities , Drug Pricing , Health Care Providers , Healthcare , HRSA , Medicaid , Pharmaceutical Industry , Prescription Drugs , Section 340B

This Week in 340B: April 2023 #3

This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets on more than 40 340B cases to provide you with a quick...more

4/18/2023  /  American Hospital Association et al v Becerra Secretary Of Health And Human Services et al , Antitrust Litigation , Covered Entities , Medicare , Pharmaceutical Industry , Pharmacies , Section 340B

This Week in 340B: April 2023

This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets on more than 40 340B cases to provide you with a quick...more

4/5/2023  /  Carve Out Provisions , Covered Entities , Medicaid , New York , Oral Argument , Restraining Orders , Section 340B

This Week in 340B - March #4

This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets on more than 40 340B cases to provide you with a quick...more

3/29/2023  /  Covered Entities , Motion to Dismiss , Section 340B

This Week in 340B: March 2023 #3

This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets on more than 40 340B cases to provide you with a quick...more

3/22/2023  /  Carve Out Provisions , Covered Entities , Distributors , Managed Care Contracts , Medicaid , New York , Prescription Drugs , Section 340B

This Week in 340B: March 2023 #2

This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets on more than 40 340B cases to provide you with a quick...more

3/16/2023  /  Covered Entities , Pharmaceutical Industry , Prescription Drugs , Section 340B

This Week in 340B: February 2023 #2

This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets on more than 40 340B cases to provide you with a quick...more

2/22/2023  /  Covered Entities , Drug Pricing , Insurance Litigation , Medicare , Medicare Part B , Pharmaceutical Industry , Prescription Drug Coverage , Reimbursements , Section 340B

This Week in 340B: February 2023

This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets on more than 40 340B cases to provide you with a quick...more

2/15/2023  /  Audits , Covered Entities , Healthcare Facilities , HRSA , Medicare , Patients , Pharmaceutical Industry , Prescription Drugs , Section 340B

This Week in 340B: January 2023 #5

This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets on more than 40 340B cases to provide you with a quick...more

2/7/2023  /  Antitrust Litigation , Appeals , Covered Entities , Department of Health and Human Services (HHS) , Drug Pricing , Manufacturers , Pharmaceutical Industry , Pharmacies , Prescription Drugs , Section 340B

340B Covered Entities May See Access Changes to Contrast Media, Radiopharmaceuticals and Other Products

340B covered entities may experience expanded access to contrast media, radiopharmaceuticals and other products at 340B prices in the coming months. Buried in the over 1,600 pages of the Consolidated Appropriations Act, 2023...more

2/2/2023  /  Consolidated Appropriations Act (CAA) , Covered Entities , Drug Pricing , Food and Drug Administration (FDA) , Over The Counter Drugs (OTC) , Pharmaceutical Industry , Prescription Drugs , Proposed Legislation , Radiopharmaceuticals , Section 340B

HHS Goes Back to the Drawing Board on the 340B ADR Process

Citing “policy and operational challenges” with the current 340B Administrative Dispute Resolution (ADR) Process, the US Department of Health and Human Services (HHS) has issued a new Proposed Rule to modify the current ADR...more

12/8/2022  /  Comment Period , Covered Entities , Department of Health and Human Services (HHS) , Dispute Resolution , Federal Rules of Civil Procedure , Good Faith , Proposed Rules , Rules of Civil Procedure , Section 340B

HRSA Filings in Genesis Shed Light on Definition of “Patient” for 340B Covered Entities

A recent case before the US Court of Appeals for the Fourth Circuit addressed the issue of which persons qualify as “patients” of a 340B program participating entity (covered entity). Court-ordered filings in ongoing...more

4/18/2022  /  Appeals , Covered Entities , Department of Health and Human Services (HHS) , HRSA , Motion to Dismiss , Patients , Prescription Drugs , Section 340B , Subject Matter Jurisdiction
60 Results
 / 
View per page
« Previous
Page: of 3
Next »

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide